These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11463049)

  • 1. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants.
    Halliday H
    J Pediatr; 2001 Jul; 139(1):163-4. PubMed ID: 11463049
    [No Abstract]   [Full Text] [Related]  

  • 2. Focal small bowel perforation: an adverse effect of early postnatal dexamethasone therapy in extremely low birth weight infants.
    Gordon PV; Young ML; Marshall DD
    J Perinatol; 2001; 21(3):156-60. PubMed ID: 11503101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postnatal dexamethasone for lung disease of prematurity.
    Gordon PV
    N Engl J Med; 2004 Jun; 350(26):2715-8; author reply 2715-8. PubMed ID: 15218578
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial.
    Doyle LW; Davis PG; Morley CJ; McPhee A; Carlin JB;
    Pediatrics; 2006 Jan; 117(1):75-83. PubMed ID: 16396863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weighing statistical certainty against ethical, clinical, and biologic expediency: the contributions of the Watterberg trial tip the scales in the right direction.
    Gordon PV
    Pediatrics; 2005 May; 115(5):1446-7; author reply 1447. PubMed ID: 15867074
    [No Abstract]   [Full Text] [Related]  

  • 6. A neonatal mouse model of intestinal perforation: investigating the harmful synergism between glucocorticoids and indomethacin.
    Gordon PV; Herman AC; Marcinkiewicz M; Gaston BM; Laubach VE; Aschner JL
    J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):509-19. PubMed ID: 18030227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone therapy and Candida sepsis in neonates less than 1250 grams.
    Pera A; Byun A; Gribar S; Schwartz R; Kumar D; Parimi P
    J Perinatol; 2002; 22(3):204-8. PubMed ID: 11948382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early closure of the Watterberg trial.
    Roberts RS
    Pediatrics; 2004 Dec; 114(6):1670-1. PubMed ID: 15574631
    [No Abstract]   [Full Text] [Related]  

  • 9. New insights into spontaneous intestinal perforation using a national data set: (2) two populations of patients with perforations.
    Attridge JT; Clark R; Walker MW; Gordon PV
    J Perinatol; 2006 Mar; 26(3):185-8. PubMed ID: 16493433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn lung treatment poses risk of intestinal perforation.
    J Am Coll Surg; 2001 Mar; 192(3):425-6. PubMed ID: 11245391
    [No Abstract]   [Full Text] [Related]  

  • 11. Minor neurological dysfunction, cognitive development, and somatic development at the age of 3 to 7 years after dexamethasone treatment in very-low birth-weight infants.
    Kutschera J; Tomaselli J; Maurer U; Mueller W; Urlesberger B
    Early Hum Dev; 2005 Mar; 81(3):281-7. PubMed ID: 15814210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up of a randomized, placebo-controlled trial of postnatal dexamethasone: blood pressure and anthropometric measurements at school age.
    Washburn LK; Nixon PA; O'Shea TM
    Pediatrics; 2006 Oct; 118(4):1592-9. PubMed ID: 17015551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of necrotizing enterocolitis in preterm infants: a 20-year experience.
    Pietz J; Achanti B; Lilien L; Stepka EC; Mehta SK
    Pediatrics; 2007 Jan; 119(1):e164-70. PubMed ID: 17145901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reopening the debate on corticosteroids: to the editor.
    Gordon PV
    Pediatrics; 2006 Jun; 117(6):2318-20; author reply 2320. PubMed ID: 16740883
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of postnatal steroids on growth and development.
    Halliday HL
    J Perinat Med; 2001; 29(4):281-5. PubMed ID: 11565195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early treatment of premature infants with steroids: neurological sequelae.
    Prescrire Int; 2007 Jun; 16(89):108-9. PubMed ID: 17582929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postnatal dexamethasone therapy and cerebral tissue volumes in extremely low birth weight infants.
    Parikh NA; Lasky RE; Kennedy KA; Moya FR; Hochhauser L; Romo S; Tyson JE
    Pediatrics; 2007 Feb; 119(2):265-72. PubMed ID: 17272615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into spontaneous intestinal perforation using a national data set (3): antenatal steroids have no adverse association with spontaneous intestinal perforation.
    Attridge JT; Clark R; Gordon PV
    J Perinatol; 2006 Nov; 26(11):667-70. PubMed ID: 17024144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulse dexamethasone does not impair growth and body composition of very low birth weight infants.
    Gilmour CH; Sentipal-Walerius JM; Jones JG; Doyle JM; Brozanski BS; Balsan MJ; Mimouni FB
    J Am Coll Nutr; 1995 Oct; 14(5):455-62. PubMed ID: 8522724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
    McEvoy C; Bowling S; Williamson K; McGaw P; Durand M
    Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.